OnKure Therapeutics, Inc. (OKUR)
3.78
-0.05
(-1.31%)
USD |
NASDAQ |
Aug 28, 16:00
3.78
0.00 (0.00%)
After-Hours: 17:53
OnKure Therapeutics Cash from Operations (Quarterly) : -10.35M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.35M |
| March 31, 2026 | -12.94M |
| December 31, 2025 | -11.51M |
| September 30, 2025 | -13.04M |
| June 30, 2025 | -13.27M |
| March 31, 2025 | -14.00M |
| December 31, 2024 | -21.02M |
| September 30, 2024 | -10.66M |
| June 30, 2024 | -6.473M |
| March 31, 2024 | -10.63M |
| December 31, 2023 | 9.383M |
| September 30, 2023 | -18.77M |
| June 30, 2023 | -16.11M |
| Date | Value |
|---|---|
| March 31, 2023 | -9.048M |
| December 31, 2022 | -15.61M |
| September 30, 2022 | -10.79M |
| June 30, 2022 | -11.96M |
| March 31, 2022 | -8.999M |
| December 31, 2021 | -10.02M |
| September 30, 2021 | -9.672M |
| June 30, 2021 | -9.701M |
| March 31, 2021 | -8.589M |
| December 31, 2020 | -5.411M |
| September 30, 2020 | -5.741M |
| June 30, 2020 | -2.937M |
| March 31, 2020 | -4.447M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Theriva Biologics, Inc. | -3.085M |
| Nkarta, Inc. | -24.22M |
| Unicycive Therapeutics, Inc. | -7.604M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.87M |
| Cash from Financing (Quarterly) | -5.38M |
| Free Cash Flow | -47.86M |
| Free Cash Flow Per Share (Quarterly) | -0.2077 |
| Free Cash Flow to Equity (Quarterly) | -10.87M |
| Free Cash Flow to Firm (Quarterly) | -10.36M |
| Free Cash Flow Yield | -55.86% |